Pharma

The UK ratifies the Unified Patent Court Agreement on World IP Day

The post below was first published on our Intellectual Property blog The UK has ratified the UPC Agreement today, 26 April 2018, which also happens to be World IP Day. The UK IP Minister announced the ratification at a World IP Day event … Continue reading

Leave a Comment

Filed under Consumer, Intellectual property, Pharma

UK Government agrees elements of the European Commission’s proposals for post-Brexit protection of EU-wide IP rights in the UK in the latest draft of the Withdrawal Agreement

The post below was first published on our Intellectual Property blog In the latest draft of the Withdrawal Agreement (19 March 2018) the UK Government and European Commission negotiators appear to have agreed text providing for the replacement of EU-wide IP rights … Continue reading

Leave a Comment

Filed under Article 50, Consumer, Intellectual property, Pharma, TMT, UK-EU negotiations

THE UNIFIED PATENT COURT (UPC) – OPEN FOR BUSINESS IN 2018?

The post below was first published on our Intellectual Property blog At the start of 2017 the expectation was that the UPC Agreement would achieve the required ratification levels and that the UK could well ratify in advance of Brexit in order to … Continue reading

Leave a Comment

Filed under Consumer, Intellectual property, Pharma

BREXIT AND IP – LAW SOCIETY NOTE CALLS FOR GOVERNMENT ACTION

The post below was first published on our Intellectual Property blog The exact mechanics of how Brexit will materialise and what it would mean for intellectual property rights in the UK is still unclear. However, time is now running short and … Continue reading

Leave a Comment

Filed under Consumer, Intellectual property, Pharma

Commission paper on IPR post-Brexit highlights the importance of resolving key issues prior to withdrawal

The European Commission has published “Position paper transmitted to EU27 on Intellectual property rights (including geographical indications)” (7 September 2017) which proposes that the (Brexit) Withdrawal Agreement should ensure that: The protection enjoyed in the United Kingdom on the basis … Continue reading

Leave a Comment

Filed under Consumer, Data protection, Intellectual property, Pharma, TMT

Patent and Pharma Update – June 2017

The post below was first published on our Intellectual Property blog Our regular Patent and Pharma Update aims to keep you informed of recent developments in United Kingdom and European law relating to patents and the pharmaceutical industry.

Leave a Comment

Filed under Consumer, Data protection, Intellectual property, Pharma, TMT

PATENT AND PHARMA UPDATE, JANUARY 2017

The post below was first published on our Intellectual Property blog Our regular patent and pharma update aims to keep you informed of recent developments in United Kingdom and European law relating to patents and the pharmaceutical industry.

Leave a Comment

Filed under Intellectual property, Pharma, TMT

BREXIT – WHAT IP ISSUES TO CONSIDER NOW

The post below was first published on our Intellectual Property blog We set out our thoughts and predictions upon how protection and enforcement of IP in the UK may be impacted once Brexit arrives. We have also suggested some immediate action points … Continue reading

Leave a Comment

Filed under Consumer, Data protection, Intellectual property, Pharma, TMT

COUNSEL’S OPINION SOUGHT BY UK IP GROUPS IN RELATION TO THE UPC AND BREXIT

Counsel’s Opinion sought by UK IP groups on the possibilities for the UK to continue to participate in the unitary patent and Unified Patent Court post Brexit now released Shortly after the Brexit referendum, the Intellectual Property Lawyers Association (IPLA), … Continue reading

Leave a Comment

Filed under Consumer, Intellectual property, Pharma

BREXIT: WHAT NOW FOR UPC AND IP IN THE UK AND ACROSS EUROPE?

Following the vote to leave, the future of the unitary patent and Unified Patent Court is far from clear.

Leave a Comment

Filed under Consumer, Intellectual property, Pharma